Holen Sie sich die Stockscreener-App
6.15
5.24%
-0.34
Handel nachbörslich:
6.21
0.06
+0.98%
Schlusskurs vom Vortag:
$6.49
Offen:
$6.57
24-Stunden-Volumen:
868.44K
Relative Volume:
0.79
Marktkapitalisierung:
$543.20M
Einnahmen:
$73.48M
Nettoeinkommen (Verlust:
$-108.30M
KGV:
-2.7333
EPS:
-2.25
Netto-Cashflow:
$-67.17M
1W Leistung:
-0.81%
1M Leistung:
-6.53%
6M Leistung:
+13.05%
1J Leistung:
+78.26%
1-Tages-Spanne:
$6.15
$6.57
1-Wochen-Bereich:
$6.09
$6.94
52-Wochen-Spanne:
$2.81
$7.79
Personalis Inc Stock (PSNL) Company Profile
Firmenname
Personalis Inc
Sektor
Branche
Telefon
650-752-1300
Adresse
6600 DUMBARTON CIRCLE, FREMONT, CA
Vergleichen Sie PSNL mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PSNL
Personalis Inc
|
6.15 | 573.23M | 73.48M | -108.30M | -67.17M | -2.25 |
|
TMO
Thermo Fisher Scientific Inc
|
484.96 | 180.56B | 43.21B | 6.58B | 6.17B | 17.29 |
|
DHR
Danaher Corp
|
202.94 | 147.13B | 24.01B | 3.41B | 4.86B | 4.70 |
|
IDXX
Idexx Laboratories Inc
|
566.50 | 45.45B | 3.93B | 894.97M | 837.70M | 10.82 |
|
A
Agilent Technologies Inc
|
119.54 | 34.14B | 6.63B | 1.17B | 1.19B | 4.05 |
|
IQV
Iqvia Holdings Inc
|
197.76 | 33.86B | 15.50B | 1.33B | 2.16B | 7.34 |
Personalis Inc Stock (PSNL) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-05-15 | Eingeleitet | Guggenheim | Buy |
| 2025-03-17 | Eingeleitet | Craig Hallum | Buy |
| 2023-02-06 | Hochstufung | Needham | Hold → Buy |
| 2022-01-07 | Hochstufung | BofA Securities | Neutral → Buy |
| 2021-11-05 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2021-11-03 | Herabstufung | Needham | Buy → Hold |
| 2021-10-15 | Fortgesetzt | Cowen | Outperform |
| 2021-09-20 | Bestätigt | Needham | Buy |
| 2021-05-06 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2021-01-28 | Eingeleitet | Truist | Buy |
| 2021-01-04 | Herabstufung | BofA Securities | Buy → Neutral |
| 2020-11-12 | Bestätigt | Needham | Buy |
| 2020-11-06 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2020-10-19 | Eingeleitet | Citigroup | Buy |
| 2020-10-08 | Eingeleitet | BTIG Research | Buy |
| 2020-08-27 | Eingeleitet | H.C. Wainwright | Buy |
| 2020-08-18 | Eingeleitet | Needham | Buy |
| 2019-09-26 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2019-07-15 | Eingeleitet | BofA/Merrill | Neutral |
| 2019-07-15 | Eingeleitet | Cowen | Outperform |
| 2019-07-15 | Eingeleitet | Morgan Stanley | Overweight |
| 2019-07-15 | Eingeleitet | Oppenheimer | Outperform |
Alle ansehen
Personalis Inc Aktie (PSNL) Neueste Nachrichten
How many analysts rate Personalis Inc. as a “Buy”Achieve breakthrough gains with smart trades - jammulinksnews.com
Multi factor analysis applied to Personalis Inc. Conservative Asset Allocation Risk Analysis - Newser
How does Personalis Inc. compare to its industry peersDiscover undervalued stocks ready to soar - jammulinksnews.com
What institutional investors are buying Personalis Inc. stockFree Advanced Stock Screener Access - jammulinksnews.com
How does Personalis Inc. generate profit in a changing economyDiscover market opportunities with expert help - jammulinksnews.com
New Product Launches: Will They Boost Personalis Inc. Stock in 2025Free Trading Group - Newser
Top Risks to Consider Before Buying Personalis Inc. StockFree Predictions - Newser
Why Personalis Inc. stock attracts strong analyst attentionFree Deep Market Trend Analysis - Newser
Why Personalis Inc. stock is on top investor watchlistsOutstanding capital appreciation - jammulinksnews.com
What analysts say about Personalis Inc. stockHigh-yield capital appreciation - PrintWeekIndia
What drives Personalis Inc. stock priceHigh-return market picks - Autocar Professional
Is Personalis Inc. a good long term investmentDynamic profit opportunities - Autocar Professional
Personalis to Announce Second Quarter 2025 Financial Results - BioSpace
Personalis Inc. Stock Analysis and ForecastMassive stock growth - jammulinksnews.com
Personalis Strengthens Leadership: New VP Gets $631K Stock Option Package in Precision Oncology Push - Stock Titan
Personalis Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | PSNL Stock News - GuruFocus
Personalis Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Yahoo Finance
Tempus AI, Inc. (TEM) and Personalis Join Forces to Take on Colorectal Cancer - MSN
From Clinics to Cancer Labs, AI Is Unlocking a New $100B+ Era in Medicine - Benzinga
How Personalis Inc. stock performs during market volatilityFree Access to Community with 300% Return - Newser
What makes Personalis Inc. stock price move sharplyFree Investment Group - Newser
Finanzdaten der Personalis Inc-Aktie (PSNL)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.19%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):